NCT00801775

Brief Summary

The purpose of this study is to analyze whether calorimetry compared to conventional methods (i.e.blood culture systems)is superior to diagnose peritoneal dialysis related peritonitis.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
8

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Aug 2008

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2008

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

December 3, 2008

Completed
1 day until next milestone

First Posted

Study publicly available on registry

December 4, 2008

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2009

Completed
Last Updated

June 13, 2011

Status Verified

June 1, 2011

Enrollment Period

7 months

First QC Date

December 3, 2008

Last Update Submit

June 10, 2011

Conditions

Peritoneal Dialysis-associated Peritonitis

Keywords

calorimetry

Outcome Measures

Primary Outcomes (1)

  • First (primary endpoint), we predict an earlier pathogen detection by calorimetry (<6 hours versus >24 hours)

    two years

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients on peritoneal dialysis

You may qualify if:

  • all patients on peritoneal dialysis

You may not qualify if:

  • none

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universitätsspital Basel

Basel, 4031, Switzerland

Location

Study Officials

  • Michael Mayr, MD

    University Hospital Basel, Transplantation Immunology and Nephrology

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

December 3, 2008

First Posted

December 4, 2008

Study Start

August 1, 2008

Primary Completion

March 1, 2009

Study Completion

March 1, 2009

Last Updated

June 13, 2011

Record last verified: 2011-06

Locations

CH(1)